TDAM USA’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $11.4M | Buy |
41,162
+31,523
| +327% | +$7.99M | 0.71% | 41 |
|
|
2021
Q3 | $2.23M | Buy |
9,639
+665
| +7% | +$164K | 0.15% | 113 |
|
|
2021
Q2 | $2.19M | Buy |
8,974
+182
| +2% | +$36.6K | 0.13% | 119 |
|
|
2021
Q1 | $1.64M | Buy |
8,792
+215
| +3% | +$42.1K | 0.1% | 142 |
|
|
2020
Q4 | $1.45M | Sell |
8,577
-419
| -5% | -$62.6K | 0.09% | 143 |
|
|
2020
Q3 | $1.33M | Sell |
8,996
-1,595
| -15% | -$247K | 0.09% | 141 |
|
|
2020
Q2 | $1.72M | Sell |
10,591
-299
| -3% | -$45.9K | 0.12% | 131 |
|
|
2020
Q1 | $1.51M | Buy |
10,890
+145
| +1% | +$19.9K | 0.13% | 138 |
|
|
2019
Q4 | $1.41M | Sell |
10,745
-499
| -4% | -$57.8K | 0.09% | 155 |
|
|
2019
Q3 | $1.26M | Sell |
11,244
-392
| -3% | -$43.6K | 0.09% | 157 |
|
|
2019
Q2 | $1.29M | Sell |
11,636
-361
| -3% | -$42.5K | 0.09% | 152 |
|
|
2019
Q1 | $1.56M | Buy |
11,997
+7
| +0.1% | +$851 | 0.11% | 139 |
|
|
2018
Q4 | $1.39M | Sell |
11,990
-1,125
| -9% | -$126K | 0.1% | 143 |
|
|
2018
Q3 | $1.35M | Sell |
13,115
-2,753
| -17% | -$275K | 0.08% | 178 |
|
|
2018
Q2 | $1.35M | Sell |
15,868
-603
| -4% | -$49.5K | 0.09% | 168 |
|
|
2018
Q1 | $1.27M | Sell |
16,471
-1,267
| -7% | -$102K | 0.08% | 173 |
|
|
2017
Q4 | $1.5M | Sell |
17,738
-710
| -4% | -$60.4K | 0.09% | 163 |
|
|
2017
Q3 | $1.58M | Sell |
18,448
-5,447
| -23% | -$447K | 0.09% | 154 |
|
|
2017
Q2 | $1.98M | Buy |
23,895
+48
| +0.2% | +$3.92K | 0.1% | 139 |
|
|
2017
Q1 | $2.01M | Buy |
23,847
+10,115
| +74% | +$810K | 0.1% | 142 |
|
|
2016
Q4 | $1.01M | Buy |
13,732
+744
| +6% | +$55.4K | 0.05% | 213 |
|
|
2016
Q3 | $1.04M | Sell |
12,988
-3,026
| -19% | -$242K | 0.05% | 222 |
|
|
2016
Q2 | $1.26M | Sell |
16,014
-1,000
| -6% | -$75.3K | 0.06% | 195 |
|
|
2016
Q1 | $1.23M | Sell |
17,014
-7,825
| -32% | -$592K | 0.06% | 198 |
|
|
2015
Q4 | $2.09M | Buy |
24,839
+10,661
| +75% | +$885K | 0.1% | 145 |
|
|
2015
Q3 | $1.19M | Sell |
14,178
-739
| -5% | -$62.4K | 0.06% | 199 |
|
|
2015
Q2 | $1.25M | Sell |
14,917
-2,624
| -15% | -$200K | 0.06% | 208 |
|
|
2015
Q1 | $1.27M | Sell |
17,541
-54
| -0.3% | -$3.84K | 0.05% | 219 |
|
|
2014
Q4 | $1.21M | Buy |
17,595
+543
| +3% | +$36.7K | 0.05% | 167 |
|
|
2014
Q3 | $1.11M | Buy |
17,052
+705
| +4% | +$44.6K | 0.05% | 175 |
|
|
2014
Q2 | $1.02M | Buy |
16,347
+357
| +2% | +$21.3K | 0.04% | 184 |
|
|
2014
Q1 | $941K | Buy |
15,990
+31
| +0.2% | +$1.73K | 0.04% | 188 |
|
|
2013
Q4 | $814K | Buy |
15,959
+7,654
| +92% | +$383K | 0.04% | 197 |
|
|
2013
Q3 | $418K | Sell |
8,305
-7,922
| -49% | -$415K | 0.02% | 198 |
|
|
2013
Q2 | $863K | Buy |
+16,227
| New | +$883K | 0.04% | 151 |
|
Other funds holding LLY
TDAM USA's LLY Position: Q4 2021 in Review
TDAM USA increased its Eli Lilly (LLY) stake by 327% in Q4 2021, buying an estimated $7.99M and bringing the position to 41,162 shares worth $11.4M. The position accounts for 0.71% of the portfolio, ranked #41.
TDAM USA first reported a position in LLY in Q2 2013 and has held it in 35 quarters since. 2,304 funds tracked by Wall St. Rank hold LLY as of Q4 2021.
- TDAM USA held 41,162 shares of Eli Lilly worth $11.4M as of Q4 2021.
- TDAM USA bought 31,523 Eli Lilly shares in Q4 2021, an estimated $7.99M.
- Eli Lilly made up 0.71% of TDAM USA's portfolio in Q4 2021, its #41 holding.
- TDAM USA first reported a position in Eli Lilly in Q2 2013 and has held it in 35 quarters since.
- 2,304 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.